B Chevallier
- Oncology top 2%
- Cancer Treatment and Pharmacology 24
- Neutropenia and Cancer Infections 6
- Cancer Diagnosis and Treatment 5
- Cancer Research top 5%
- Breast Cancer Treatment Studies 14
- Dermatology top 2%
- Chemotherapy-related skin toxicity 6
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 5
-
- Nausea and vomiting management 6
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
- Co-authors
- Henri RochéP. FumoleauJean Pierre OlivierPierre KerbratP. CholletP HurteloupP. FargeotVéronique Dièras
- Cited by
- OncologyCancer ResearchDermatology
- Journals
- European Journal of Cancer (9 papers)British Journal of Cancer (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- FranceBelgiumNetherlands
In The Last Decade
B Chevallier
66 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.2k
- Cancer Research 490
- Dermatology 176
- Pathology and Forensic Medicine 238
- Reproductive Medicine 94
Countries citing papers authored by B Chevallier
This map shows the geographic impact of B Chevallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Chevallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Chevallier more than expected).
Fields of papers citing papers by B Chevallier
This network shows the impact of papers produced by B Chevallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Chevallier. The network helps show where B Chevallier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B Chevallier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | Marfan syndrome and fibrillin disorders. | 2000 | 12 |
| 3 | 2000 | 20 | |
| 4 | 1999 | 3 | |
| 5 | 1998 | 348 | |
| 6 | 1998 | 5 | |
| 7 | 1997 | 20 | |
| 8 | 1996 | 74 | |
| 9 | 1995 | 1 | |
| 10 | 1995 | 57 | |
| 11 | 1994 | 36 | |
| 12 | [Metastatic basal cell carcinoma]. | 1993 | 0 |
| 13 | 1993 | 46 | |
| 14 | 1993 | 13 | |
| 15 | 1993 | 69 | |
| 16 | 1993 | 0 | |
| 17 | 1993 | 21 | |
| 18 | Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer. | 1992 | 6 |
| 19 | 1990 | 90 | |
| 20 | 1989 | 12 |
About B Chevallier
B Chevallier is a scholar working on Oncology, Cancer Research, Dermatology, Reproductive Medicine and Pathology and Forensic Medicine, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (14 papers), Nausea and vomiting management (6 papers), Chemotherapy-related skin toxicity (6 papers), Neutropenia and Cancer Infections (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (490 citations), Dermatology (176 citations), Pathology and Forensic Medicine (238 citations) and Reproductive Medicine (94 citations). B Chevallier has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Henri Roché, P. Fumoleau, Jean Pierre Olivier, Pierre Kerbrat, P. Chollet, P Hurteloup, P. Fargeot, Véronique Dièras, N. Azli and A. Riva. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology and Injury Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.